Anticancer Therapy-Induced Alterations in Tumor-Derived Extracellular Vesicles: Molecular Mechanisms and Biological Effects
Molecules · 29.10.2026 · 31 (21) · 3901
DOI: 10.3390/molecules31213901 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 29.10.2026. Verfasst von Mi Eun Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science, Immunology Research Lab & BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Chos…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANCHOR program, Jeonnam-Gwangju Special Metropolitan City, Republic of Korea.
Abstract (Originalsprache)
Anticancer treatment alters the secretion and molecular composition of tumor-derived extracellular vesicles (EVs). Chemotherapy, ionizing radiation, and molecularly targeted therapy are associated with changes in EV-associated microRNAs (miRNAs), circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), small nuclear RNAs (snRNAs), proteins, metabolic components, and tumor-associated antigens. Some treatment-associated EV changes are supported by molecular characterization alone, whereas others have been evaluated for functional effects in recipient cells. At the donor-cell level, altered EV release and cargo loading involve RAB family small GTPases, lysosomal degradation, multivesicular body–plasma membrane fusion mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins, the exocyst component Exo70, and RNA- and protein-loading processes. In recipient tumor cells, reported responses include changes in WNT/β-catenin and NOTCH signaling, phosphoinositide 3-kinase/protein kinase B (PI3K/AKT), mitogen-activated protein kinase (MAPK), platelet-derived growth factor receptor α (PDGFRα) signaling, glutamine metabolism, and oxidative responses. Evidence supporting individual cargo–response relationships includes both association-based observations and perturbation-based functional validation. In immune cells, C-X-C motif chemokine ligand 1 (CXCL1)-containing EVs increase programmed death-ligand 1 (PD-L1) expression in macrophages, and PD-L1-positive small extracellular vesicles (sEVs) reduce CD8+ T-cell proliferation and granzyme B production, whereas radiation-induced sEVs carrying tumor-associated antigens and heat shock proteins increase antigen presentation and CD4+ and CD8+ T-cell responses. This review separates treatment-associated molecular EV alterations from experimentally evaluated recipient-cell effects to clarify the evidence supporting therapy-induced EV responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science, Immunology Research Lab & BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Chosun University, Gwangju 61452, Republic of Korea.
ORCID-Profile: Jun Sik Lee
Förderung
- ANCHOR program
- Jeonnam-Gwangju Special Metropolitan City, Republic of Korea
Zitieren
APA
Kim, M. E., & Lee, J. S. (2026). Anticancer Therapy-Induced Alterations in Tumor-Derived Extracellular Vesicles: Molecular Mechanisms and Biological Effects. Molecules, 31(21), 3901. https://doi.org/10.3390/molecules31213901
Vancouver
Kim ME, Lee JS. Anticancer Therapy-Induced Alterations in Tumor-Derived Extracellular Vesicles: Molecular Mechanisms and Biological Effects. Molecules. 2026;31(21):3901. doi:10.3390/molecules31213901
BibTeX
@article{Kim2026,
author = {Kim, Mi Eun and Lee, Jun Sik},
title = {Anticancer Therapy-Induced Alterations in Tumor-Derived Extracellular Vesicles: Molecular Mechanisms and Biological Effects},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {3901},
doi = {10.3390/molecules31213901}
}
EUVIMED